Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2016

Jun 3, 2016

34117_dirs_2016-06-03_4eea0227-8156-4577-8c59-6bcddf13ffe6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2016-06-01

Reporting Person: HERMS HENRY P (V.P., Finance & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-06-01 Common Stock M 2000 $2.58 Acquired 24125 Direct
2016-06-01 Common Stock S 1000 $3.27 Disposed 23125 Direct
2016-06-01 Common Stock S 500 $3.28 Disposed 22625 Direct
2016-06-02 Common Stock S 500 $3.23 Disposed 22125 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-06-01 Employee Stock Option $2.58 M 2000 Disposed 2016-06-01 Common Stock (2000) Direct

Footnotes

F1: Right-To-Buy, pursuant to the ITUS Corporation 2003 Share Incentive Plan.